SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

DOI: 10.1186/s12933-019-0816-2

Keywords: Type 2 diabetes mellitus, SGLT2, Empagliflozin, Oxidative stress, Myocardial fibrosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Weight gain, and blood and serum parameters after 8 weeks of treatment in control and diabetic mic

Full-Text